FIRST AMENDMENT TO FACILITY AGREEMENTFacility Agreement • November 10th, 2014 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations
This FIRST AMENDMENT TO FACILITY AGREEMENT (the “First Amendment”), dated as of September 22, 2014, by and among Infinity Pharmaceuticals, Inc., a Delaware corporation (the “Borrower”), and the lenders party hereto, set forth on the signature page of this First Amendment (together with their successors and assigns, the “Lenders” and together with the Borrower, the “Parties”), amends that certain Facility Agreement dated as of February 24, 2014 by and among the Parties (the “Original Agreement” and as amended by the First Amendment, the “Facility Agreement”). Capitalized terms used herein without definition shall have the meanings ascribed to such terms in the Original Agreement.
AMENDMENT TO AMENDED AND RESTATED DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • November 10th, 2014 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment to Amended and Restated Development and License Agreement (“Amendment”) is made as of this 29th day of July, 2014 (the “Amendment Effective Date”) by and between Intellikine LLC, a limited liability company organized and existing under the laws of the State of Delaware and successor to Intellikine, Inc. (“Intellikine”), and Infinity Pharmaceuticals, Inc., a company organized and existing under the laws of the State of Delaware (“Infinity”). Intellikine and Infinity are each referred to individually as a “Party” and together as the “Parties”.
LEASE OF PREMISES AT 784 MEMORIAL DRIVE CAMBRIDGE, MASSACHUSETTS FROM BHX, LLC, AS TRUSTEE OF 784 REALTY TRUST TO INFINITY PHARMACEUTICALS, INC.Lease Agreement • November 10th, 2014 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations
The following is a summary of certain basic terms of this Lease which is intended for the convenience and reference of the parties. Capitalized terms used, but not defined, in this Summary of Basic Terms have their defined meanings in this Lease. In addition, some of the following items or terms are incorporated into this Lease by reference to the item or term or to this Summary of Basic Terms.
SEVENTH AMENDMENT TO LEASELease Agreement • November 10th, 2014 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations
Landlord and Tenant agree that the equipment described below may be removed by Tenant from the Premises, in each case except where such equipment was purchased using the Tenant Improvement Allowance:
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN INFINITY PHARMACEUTICALS, INC. AND ABBVIE INC.Collaboration and License Agreement • November 10th, 2014 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Collaboration and License Agreement (this “Agreement”) is made and effective as of the 2nd day of September, 2014 (the “Execution Date”) by and between Infinity Pharmaceuticals, Inc., a Delaware corporation, with offices at 780 Memorial Drive, Cambridge, MA 02139, USA (“Infinity”) and AbbVie Inc., a Delaware corporation, with offices at 1 North Waukegan Road, North Chicago, IL 60064 (“AbbVie”).
